# A Study of the Impact of Hemophilia and Its Treatment on Brain Development, Thinking and Behaviour in Children With Hemophilia

> **NCT03660774** · — · COMPLETED · sponsor: **Novo Nordisk A/S** · enrollment: 563 (actual)

## Conditions studied

- Haemophilia A
- Haemophilia B

## Interventions

- **OTHER:** No treatment given

## Key facts

- **NCT ID:** NCT03660774
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-09-27
- **Primary completion:** 2019-10-11
- **Final completion:** 2019-10-11
- **Target enrollment:** 563 (ACTUAL)
- **Last updated:** 2019-11-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03660774

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03660774, "A Study of the Impact of Hemophilia and Its Treatment on Brain Development, Thinking and Behaviour in Children With Hemophilia". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03660774. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*